P95
Clinical Research Solutions in vaccines and infectious diseases
- B2B
About P95
A global provider of clinical research solutions specializing in vaccines and infectious diseases, offering services such as clinical studies, epidemiology, and medical writing
Key facts
- Industry
- Research Services
- Company size
- 51–250 employees
- Headquarters
- leuven, flemish region, Belgium
- Founded
- 2011
- Revenue
- $11.6M – $79.8MTamtam estimate
- Website
- p-95.com
- linkedin.com/company/p95
P95 in the news
- Ampersand backs Belgian CRO P95 BV with eye on expansion
Ampersand invested in Belgian CRO P95 to expand its vaccine and infectious disease clinical research services globally.
- Leuvense chouchou van 'big pharma', P95, rijgt overnames aan mekaar
P95 is growing its clinical research capacity through acquisitions in multiple countries, targeting the US next.
- P95 Welcomes Laurence De Moerlooze as Chief Medical Officer to Oversee Clinical and Epidemiology Operations
Laurence De Moerlooze joins P95 as Chief Medical Officer to lead vaccine-focused clinical and epidemiology operations globally.
- P95 Acquires 4Clinics to Expand Global CRO Services, Strengthen Position as Market Leader
P95 acquired 4Clinics to expand its global CRO services and strengthen its leadership in vaccines and infectious diseases research.
P95 at a glance
P95 is a B2B company in the Research Services industry, headquartered in leuven, flemish region, Belgium.
P95 was founded in 2011.
P95 has 51–250 employees.
P95's revenue is $11.6M – $79.8M (Tamtam estimate).
Selling to companies like P95?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies